Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check3 days agoChange DetectedThe history now includes a new revision entry, v3.6.5, and the previous entry, v3.6.4, has been removed. This reflects an update to the page's revision version rather than changes to the study data.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe revision label on the page changed from v3.6.3 to v3.6.4, indicating a small version update to the page rendering. This update does not modify the study information shown.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now shows revision v3.6.3, indicating a system update to the page rather than a modification of trial information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe history now includes Revision: v3.6.2, replacing Revision: v3.6.0, indicating an updated deployment of the record history page.SummaryDifference0.1%

- Check53 days agoChange DetectedSeveral core sections and their version entries were removed from the study record history (e.g., Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Contacts/Locations, Study Design, Recruitment Status), reducing visible trial information in the record.SummaryDifference15%

- Check61 days agoChange DetectedThe history adds that recruitment is closed and updates the record revision to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.2%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.